Your Messages Inbox
Your Article Summary
See Latest ArticlesUnited States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
BioMarin Pharmaceutical Inc. announced that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Telmisartan/amlodipine (Twynsta): approved for high blood pressure
Formulary , 12/16/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09
Article Search
Sponsor